Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States

Código QR

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States

Samaneh Kalirai,1 Jasmina I Ivanova,2 Magaly Perez-Nieves,1 Judith J Stephenson,3 Irene Hadjiyianni,1 Michael Grabner,3 Roy Daniel Pollom,1 Caroline Geremakis,3 Beverly L Reed,1 Lawrence Fisher4 1Eli Lilly and Company, Indianapolis, IN, USA; 2Analysis Group Inc., New York, NY, USA; 3HealthCore Inc.,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kalirai S, Ivanova JI, Perez-Nieves M, Stephenson JJ, Hadjiyianni I, Grabner M, Pollom RD, Geremakis C, Reed BL, Fisher L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	type 2 diabetes mellitus basal insulin patient survey medication persistence Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/ee0bcfb9873f45e1941eba8d2c0c710c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Modern basal insulins: an ongoing story or the start of a new era?
por: Ivan Ivanovich Dedov
Publicado: (2015)

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
por: Cai X, et al.
Publicado: (2020)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
por: Alsu Gafurovna Zalevskaya, et al.
Publicado: (2010)

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
por: Kress S, et al.
Publicado: (2021)

Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial
por: Hu X, et al.
Publicado: (2021)

Insulin degludec is a new ultra-long-acting insulin analogue
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2013)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau IT, et al.
Publicado: (2017)

Acidificación urinaria basal en escolares normales
por: OCHOA A,EDECIA, et al.
Publicado: (1975)

El estándar de creatinina en la predicción del metabolismo basal
por: CORREA B,OSCAR
Publicado: (1944)

Multicenter Real-World Assessment of the Effectiveness of V-Go Wearable Insulin Delivery Device in Adult Patients with Type 2 Diabetes (ENABLE Study): A Retrospective Analysis
por: Hundal R, et al.
Publicado: (2020)

Intravascular Basal Cell Carcinoma Hiding under a Keratoacanthoma
por: Austin Dunn, et al.
Publicado: (2021)

rDNA insulin glargine U300 – a critical appraisal
por: Wang F, et al.
Publicado: (2016)

In Situ Melanoma in Collision With a Basal Cell Carcinoma in a Patient With Basal Cell Nevus Syndrome: Clinical and Dermoscopic Features
por: Giulia Briatico, et al.
Publicado: (2019)

Photodynamic therapy at the treatment of recurrent basal cell skin cancer
por: A. V. Belonogov, et al.
Publicado: (2014)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
por: M. V. Shestakova, et al.
Publicado: (2021)

Activation of the Hedgehog and Wnt/β-Catenin Signaling Pathways in Basal Cell Carcinoma
por: Tomoaki Takada
Publicado: (2021)

Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
por: Silvia S. Iannazzone, et al.
Publicado: (2018)

Dorso-ventral heterogeneity in tracheal basal stem cells
por: Tomomi Tadokoro, et al.
Publicado: (2021)

Large Pore Basal Cell Carcinoma: A Case Report
por: Ana Ines Lösch, et al.
Publicado: (2021)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Use of basal insulin and the associated clinical outcomes among elderly nursing home residents with type 2 diabetes mellitus: a retrospective chart review study
por: Davis KL, et al.
Publicado: (2014)

Cell size and basal metabolic rate in hummingbirds
por: Opazo,Juan C., et al.
Publicado: (2005)

Influence of the glutathione s-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma
por: Leite,Janaína L, et al.
Publicado: (2007)

Early Onset Basal Cell Carcinoma: Surgical Approach
por: Betekhtin M., et al.
Publicado: (2014)

Basal cell carcinomas in elderly patients treated by cryotherapy
por: Chiriac A, et al.
Publicado: (2013)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Radiation-induced basal cell carcinoma
por: Omid Zargari
Publicado: (2015)

Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
por: Chan WB, et al.
Publicado: (2017)

Infundibulocystic basal cell carcinoma: dermoscopic findings and histologic correlation
por: Rodrigo Roldán-Marín, et al.
Publicado: (2014)

Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
por: Laura Eibenschutz, et al.
Publicado: (2021)

RELUCTANCE OF PATIENTS WITH DIABETES MELLITUS TO INSULIN THERAPY; PSYCHOLOGICAL INSULIN RESISTANCE
por: Umair Ali, et al.
Publicado: (2021)

The value of patient-reported outcomes in patients with type 2 diabetes mellitus receiving insulin therapy: assessment of quality of life and hypoglycemia problems
por: Tat'yana Ivanovna Ionova, et al.
Publicado: (2015)

Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid
por: De Paula,Flávia MM, et al.
Publicado: (2011)

Neglected Basal Cell Carcinoma With Fatal Outcome
por: Jenna Pakka, et al.
Publicado: (2019)

Dermoscopy of Vulvar Pigmented Basal Cell Carcinoma
por: Gabriel Salerni, et al.
Publicado: (2019)

Dermoscopy and reflectance confocal microscopy in pedunculated basal cell carcinoma
por: Seda Yildiz, et al.
Publicado: (2017)

National advisory board on diabetes mellitus: unsolved issues and new opportunities for diabetes treatment
por: Gagik Radikovich Galstyan
Publicado: (2014)